ADUC
RegisteredWord Mark
•
Ownership
KC
Owner Name
Type: Organization / Corporation
Address
6-29, Nishiki 3-chome,, Naka-ku, Nagoya-shi, Aichi-ken 460-8625
Japan
Critical Dates
First Use Date
Not filed yet
Filing Date
May 20, 2025
Registration Date
Dec 23, 2025
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease...
Mark Elements
Text Mark
ADUC
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 05:57 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
ADUC is a standard character word mark covering pharmaceutical preparations, veterinary preparations, vaccines, and therapeutic medicines/antibodies in International Class 005 for treating and preventing diseases including cardiovascular, cerebrovascular, diabetes, cancer, immunological disorders, infections, pain, neurological conditions, kidney disease, skin disease, osteoporosis, ophthalmic disorders, and aging-related diseases, with additional domestic classes 006, 018, 044, 046, 051, and 052. The mark is owned by Kowa Company, Ltd., a Japanese corporation. It is registered on the Principal Register (Reg. No. 8073026) as of December 23, 2025, based on an international registration (WO 1867370) via Section 66A, with automatic protection in the US until January 31, 2027, and expiration on May 20, 2035. No oppositions or legal proceedings are present.
Recent Activity
The application (Ser. No. 79429112), filed May 20, 2025, via Madrid Protocol with domestic notification on July 31, 2025, was published for opposition on November 4, 2025, after approval on October 2, 2025. It proceeded to registration on the Principal Register on December 23, 2025, followed by a final disposition notice to the International Bureau on January 22, 2026.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach